These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19889531)

  • 1. Expression systems for therapeutic glycoprotein production.
    Durocher Y; Butler M
    Curr Opin Biotechnol; 2009 Dec; 20(6):700-7. PubMed ID: 19889531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Process development for a recombinant Chinese hamster ovary (CHO) cell line utilizing a metal induced and amplified metallothionein expression system.
    Huang EP; Marquis CP; Gray PP
    Biotechnol Bioeng; 2004 Nov; 88(4):437-50. PubMed ID: 15459913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of cell engineering strategies for improved therapeutic protein production in CHO cells.
    Mohan C; Kim YG; Koo J; Lee GM
    Biotechnol J; 2008 May; 3(5):624-30. PubMed ID: 18293320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological significance of glycosylation in therapeutic proteins.
    Li H; d'Anjou M
    Curr Opin Biotechnol; 2009 Dec; 20(6):678-84. PubMed ID: 19892545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical caspase inhibitors enhance cell culture viabilities and protein titer.
    Arden N; Ahn SH; Vaz W; Rhodes M; Hancock C; Abitorabi MA; Betenbaugh MJ
    Biotechnol Prog; 2007; 23(2):506-11. PubMed ID: 17381129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appropriate mammalian expression systems for biopharmaceuticals.
    Werner RG; Noé W; Kopp K; Schlüter M
    Arzneimittelforschung; 1998 Aug; 48(8):870-80. PubMed ID: 9748718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Process parameter shifting: Part II. Biphasic cultivation-A tool for enhancing the volumetric productivity of batch processes using Epo-Fc expressing CHO cells.
    Trummer E; Fauland K; Seidinger S; Schriebl K; Lattenmayer C; Kunert R; Vorauer-Uhl K; Weik R; Borth N; Katinger H; Müller D
    Biotechnol Bioeng; 2006 Aug; 94(6):1045-52. PubMed ID: 16736532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of a secreted glycoprotein from an inducible promoter system in a perfusion bioreactor.
    Lipscomb ML; Mowry MC; Kompala DS
    Biotechnol Prog; 2004; 20(5):1402-7. PubMed ID: 15458323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of dynamic online fed-batch strategies on metabolism, productivity and N-glycosylation quality in CHO cell cultures.
    Chee Furng Wong D; Tin Kam Wong K; Tang Goh L; Kiat Heng C; Gek Sim Yap M
    Biotechnol Bioeng; 2005 Jan; 89(2):164-77. PubMed ID: 15593097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sodium butyrate on the production, heterogeneity and biological activity of human thrombopoietin by recombinant Chinese hamster ovary cells.
    Sung YH; Song YJ; Lim SW; Chung JY; Lee GM
    J Biotechnol; 2004 Sep; 112(3):323-35. PubMed ID: 15313009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moss bioreactors producing improved biopharmaceuticals.
    Decker EL; Reski R
    Curr Opin Biotechnol; 2007 Oct; 18(5):393-8. PubMed ID: 17869503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing recombinant glycoprotein sialylation through CMP-sialic acid transporter over expression in Chinese hamster ovary cells.
    Wong NS; Yap MG; Wang DI
    Biotechnol Bioeng; 2006 Apr; 93(5):1005-16. PubMed ID: 16432895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of heat shock proteins (HSPs) in CHO cells for extended culture viability and improved recombinant protein production.
    Lee YY; Wong KT; Tan J; Toh PC; Mao Y; Brusic V; Yap MG
    J Biotechnol; 2009 Aug; 143(1):34-43. PubMed ID: 19527755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene amplification and vector engineering to achieve rapid and high-level therapeutic protein production using the Dhfr-based CHO cell selection system.
    Cacciatore JJ; Chasin LA; Leonard EF
    Biotechnol Adv; 2010; 28(6):673-81. PubMed ID: 20416368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of tetracycline-responsive recombinant protein production and effect on cell growth and ER stress in mammalian cells.
    Jones J; Nivitchanyong T; Giblin C; Ciccarone V; Judd D; Gorfien S; Krag SS; Betenbaugh MJ
    Biotechnol Bioeng; 2005 Sep; 91(6):722-32. PubMed ID: 15981277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of transient gene expression and culture viability using Chinese hamster ovary cells overexpressing Bcl-x(L).
    Majors BS; Betenbaugh MJ; Pederson NE; Chiang GG
    Biotechnol Bioeng; 2008 Oct; 101(3):567-78. PubMed ID: 18727128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High yields of monomeric recombinant beta-interferon from macroporous microcarrier cultures under hypothermic conditions.
    Tharmalingam T; Sunley K; Butler M
    Biotechnol Prog; 2008; 24(4):832-8. PubMed ID: 19194894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum-free large-scale transient transfection of CHO cells.
    Derouazi M; Girard P; Van Tilborgh F; Iglesias K; Muller N; Bertschinger M; Wurm FM
    Biotechnol Bioeng; 2004 Aug; 87(4):537-45. PubMed ID: 15286991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of cell culture conditions to control N-glycosylation site-occupancy of recombinant glycoproteins expressed in CHO cells.
    Gawlitzek M; Estacio M; Fürch T; Kiss R
    Biotechnol Bioeng; 2009 Aug; 103(6):1164-75. PubMed ID: 19418565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current achievements in the production of complex biopharmaceuticals with moss bioreactors.
    Decker EL; Reski R
    Bioprocess Biosyst Eng; 2008 Jan; 31(1):3-9. PubMed ID: 17701058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.